Vaccine makers claims efficacy against Omicron variant of Covid-19

Omicron has been the dominant strain across the world since January, quickly replacing the Delta variant that had caused a devastating second wave in India

With Omicron and its sub-variants spreading rapidly across the globe, vaccine makers have started claiming efficacy of their Covid-19 vaccines against this Sars-CoV-2 variant.

On Wednesday, Russia’s Gamaleya Institute claimed that taking one shot or two shot boosters of either Sputnik Light or Sputnik V resulted in significant protection against chances of hospitalisation caused by Omicron.

The Sputnik V vaccine makers said that a study conducted by a team of Russian scientists including representatives of City Clinical Hospital and the Gamaleya National Research Center of Epidemiology and Microbiology found that Sputnik V’s efficacy against hospitalisation caused by Omicron